Sequenom Revenue Soars
Sequenom Inc. (Nasdaq: SQNM) widened losses for the third quarter to 26 cents per share from 19 cents per share a year earlier but revenue soared and sales of its Down syndrome test is expected to exceed expectations. The stock price climbed 57 cents to close at $3.60.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here